大肠杆菌的共振散射光谱研究

研究了大肠杆菌的共振散射光谱.它在470nm、510nm和730nm产生三个瑞利散射峰.当激发波长为470nm(6.38×1014Hz)时,大肠杆菌溶液在470nm(6.38×1014Hz)和940nm(1/2×6.38×1014Hz)分别产生一个瑞利散射峰和一个1/2分频散射峰;当激发波长为510nm(5.88×1014Hz)时,在510nm产生一个共振散射峰;当激发波长为730nm(4.11×1014Hz)时在365nm(2×4.11×1014Hz)和730nm(4.11×1014Hz)分别产生一个2倍频散射峰和一个共振散射峰.分频散射和倍频散峰与共振散射峰具有相似的散射行为.大肠杆菌的浓度在0.074～38×108个/mL范围内与共振光散射强度I470nm、I510nm、I730nm成良好线性关系.     

酿酒酵母细胞的共振散射光谱研究

酿酒酵母在磷酸缓冲溶液中与培养基中都有很强的共振瑞利散射,在缓冲溶液中最大散射峰在392 nm处,在310 nm、420 nm、445 nm、457 nm、469 nm、482nm处也有弱的散射峰;在培养基中最大散射峰在483 nm处,在507 nm、527 nm、541 nm处有弱的共振散射峰.在最大散射峰处,共振散射强度与细胞浓度有良好的线性关系,线性范围分别是0～2.2×106个/mL、0～1.3×107个/mL,检出限分别为4.7×104个/mL、1.0×105个/mL.将共振瑞利散射技术应用于检测细胞数,具有操作简便、灵敏度高等的优点.     

钙试剂-蛋白质体系的共振光散射光谱研究

基于蛋白质对钙试剂共振光散射的增强作用,拟定了一种测定蛋白质的共振光散射法。在pH 4.00的水溶液中,钙试剂在595 nm处的共振光散射增强与蛋白质浓度呈线性关系。此方法对人血清白蛋白、牛血清白蛋白的检出限分别可达0.068和0.085μg/mL。同时得到钙试剂与人血清白蛋白和牛血清白蛋白的结合常数(K)以及结合位点数(n)分别为8.15×104mol/L,0.18和7.67×104mol/L,1.5。     

柑桔溃疡菌的共振散射光谱

研究了柑桔溃疡菌的共振散射光谱,在330、425、465和695 nm产生四个共振散射峰.当激发波长为330 nm （9.09×1014 Hz）时,溃疡菌溶液在330 nm（9.09×1014 Hz）、660 nm（1/2×9.09×1014 Hz）和990 nm（1/3×9.09×1014 Hz）分别产生一共振散射峰和1/2、1/3两个分频散射峰;当激发波长为465 nm（6.45×1014 Hz）时,在456 nm(6.45×1014 Hz)和930 nm(1/2×6.45×1014 Hz)分别产生一个共振散射峰和一个1/2分频射峰; 当激发波长为930 nm(3.23×1014 Hz)时,在930 nm (3.23×1014 Hz)、620 nm(3/2×3.23×1014 Hz)、465 nm(2×3.23×1014 Hz) 和310 nm (3×3.23×1014 Hz)分别产生一个共振散射峰,一个3/2分频共振散射峰,一个2倍频共振散射峰和一个3倍频共振散射峰.柑桔溃疡菌是一种非线性散射光学介质.分频散射和倍频散射峰与共振散射峰具有相似的散射行为.     

流式细胞术散射光谱法测定痕量银的研究

以TritonX_100为乳化剂,用AgNO3与NaCl反应制备了AgCl微粒体系。应用流式细胞仪和荧光光度计分别研究了液相流式AgCl微粒体系的流式细胞术(FCM)光散射及动态散射光谱(DLS)特性,建立了流式细胞术散射光检测痕量Ag+的新方法。实验发现,Ag+质量浓度分别在1.50×10-4~5.00μg/mL、4.80×10-3~20.99μg/mL范围内,流式、动态AgCl微粒体系散射光强度与Ag+质量浓度都呈现线性关系(r=0.995 0和0.999 8),方法检出限分别为0.045、1.50 ng/mL。     

流动注射后化学发光法测定异烟肼

本文发现了异烟肼在铁氰化钾-钙黄绿素化学发光反应体系中的后化学发光反应。优化了反应条件,建立了一种利用后化学发光反应测定异烟肼的流动注射化学发光分析法。方法的检出限为6×10-8g/mL, 相对标准偏差为1.8% (2.0×10-6 g/mL 异烟肼,n=11）,线性范围为2.0×10-7~1.0×10-5 g/mL。此法已用于异烟肼片剂中异烟肼含量的测定,结果与药典方法测定值一致。     

黄原胶分子量的研究

Dintzis曾用经典光散射法测得经90℃、4 mool/L尿素处理3h的黄原胶分子量为2×10~6,不加热的分子量为13×10~6和50×10~6,但未知确切数据.Rinaudo和Milas以相同的方法在l×10~(-3)～l mool/L的氯化钠溶液中测得黄原胶的分子量为2×10~6.Southwick用动态光散射法在4 mol/L尿素中测出其分子量为2.16×10~6.G Holzwarth用透射电镜测出分子量为4×10~6～20×10~6之后,他又通过测定沉降系数和特性粘数,由MFS等式算出黄原胶原始分子量为15×10~6.可见,虽然实验方法和样品不同,但仍可确定其分子量在2×10~650×10~6之间。     

聚鲁米诺-金属离子复合物膜的电化学发光特性及其分析应用研究

建立了一种基于电聚合和配位效应构建聚鲁米诺-金属离子复合物膜修饰电极测定尿素的电化学发光分析新方法, 并且提出了一种优化聚鲁米诺电化学发光分析特性的新思路. 在最佳条件下, 增敏电化学发光信号与尿素的质量浓度在2.0×10-9—1.0×10-7 g/mL 范围内呈线性关系, 检出限为1.7×10-10 g/mL.     

共振光散射比浊法测定钾

近年来共振光散射技术已成功用于生化、环境、食品等分析领域[1 5]。本文基于四苯硼钠与钾作用产生难溶盐,使用表面活性剂使悬浊液保持稳定,共振光散射比浊法试验发现在pH=8 78的缓冲溶液、2mL浓度为5×10-3mol/L的四苯硼钠溶液,8mL乙二醇作为分散剂的条件下,该体系空白溶液的RLS较弱,当加入一定量的钾离子后体系RLS强度明显增强,且体系在0 0～4 6×10-4mol/L范围内线性关系良好,回归方程为:I=3 828cK+-0 071　R=0 9969检测限以3δ计算为0 124×10-6mol/L。该法用于尿液中钾含量的测定简便快捷,回收率92 6～103 5%之间,相对误差0 …     

流动注射化学发光法测定没食子酸

基于在碱性介质中,没食子酸(Gallicacid)被过氧化氢氧化能产生化学发光,而甲醛对该体系的化学发光有较强增敏作用,据此建立了流动注射化学发光法测定没食子酸的新方法。该法简单、快速、线性范围较宽。本法测定没食子酸的线性范围为2.0×10-6～2.0×10-4g/mL,检出限达5.8×10-7g/mL,采样频率为120个/小时。对4.0×10-5g/mL没食子酸溶液连续11次测定的相对标准偏差为2.52%。该方法已成功地用于橄榄中没食子酸含量的测定。     

化学发光磁酶免疫法检测O157:H7大肠埃希菌

通过自行制备的免疫磁珠结合新型发光底物(AMPPD), 改进了化学发光磁酶免疫检测法, 对人工猪肉样品中O157:H7大肠埃希菌进行了检测, 并与人工计数法进行了比较.     

Luminol-K_3[Fe(CN)_6]流动注射化学发光体系检测头孢吡肟

在碱性介质中,头孢吡肟对Luminol-K3[Fe(CN)6]化学发光体系具有明显的增强作用,基于此建立了流动注射化学发光法测定头孢吡肟的新方法。在优化实验条件下,化学发光增强强度与头孢吡肟的浓度在3.0×10-6~4.0×10-5g/m L范围内呈良好的线性关系,检出限为2.8×10-6g/m L。对2.0×10-5g/m L头孢吡肟平行测定11次,相对标准偏差(RSD)为1.5%。该方法用于头孢吡肟针剂的测定,结果满意。     

Flow‐Injection Chemiluminescence Analysis of Cloperastione Hydrochloride

Abstract

A new chemiluminescence (CL) reaction was observed when cloperastine hydrochloride was injected into the reaction mixture after the CL reaction of Ce(IV) and sodium sulfite finished. A new flow injection CL method for the determination of cloperastine hydrochloride was established based on the CL reaction. The relative standard deviation (RSD) for the determination of cloperastine hydrochloride was 1.3% (n=11, c=1.0×10^?6 g/mL). The CL intensity responded linearly to the concentration of cloperastine hydrochloride in the range 2.0×10^?7～2.0×10^?5 g/mL (r=0.9962). The detection limit was 5×10^?8 g/mL cloperastine hydrochloride. The method had been applied to the determination of cloperastine hydrochloride in tablets with satisfactory results.     

纳米金催化Luminol-AgNO_3化学发光体系测定盐酸阿米替林

碱性条件下,纳米金对Luminol-Ag NO3化学发光体系有增敏作用,盐酸阿米替林对该化学发光体系有显著的增敏作用。基于此,在优化化学发光反应条件的基础上,提出了测定盐酸阿米替林的新方法,并对其化学发光机理进行了探讨。该法测定盐酸阿米替林的线性范围为3.0×10-9~3.0×10-7g/m L,相关系数(r)为0.999 4,检出限(S/N=3)为2.1×10-9g/m L,相对标准偏差(RSD)为2.0%(n=11,ρ盐酸阿米替林=5.0×10-8g/m L)。该法已成功用于药物制剂中盐酸阿米替林含量的测定。     

木质素磺酸钠改性聚砜膜的制备及其在正渗透膜中的应用

采用木质素磺酸钠作为亲水添加剂,通过浸没沉淀相转化法制备了木质素磺酸钠共混改性聚砜膜,以改善聚砜膜的亲水性,并用作正渗透膜的支撑层,以降低内浓差极化效应.利用扫描电子显微镜、衰减全反射傅里叶变换红外光谱仪、水接触角仪等研究了不同木质素磺酸钠添加量对聚砜膜的结构和表面性质的影响.结果表明,添加木质素磺酸钠后,聚砜膜的指状孔变得规整且狭长.水接触角实验证实添加木质素磺酸钠能改善聚砜膜的亲水性,当木质素磺酸钠含量为0.4 wt%时,聚砜膜的表面水接触角可降低至65°.正/反渗透测试装置分别用于表征正渗透膜的传质性质和结构参数.结果表明,以0.4 wt%木质素磺酸钠改性聚砜膜为支撑层的正渗透膜的水渗透性能(A=3.12×10~(-5) LMH×Pa~(-1))优于纯聚砜基底正渗透膜(0.76×10~(-5)LMH×Pa~(-1)),而且前者的结构参数(S=2010mm)远小于后者(3450mm),说明木质素磺酸钠改性聚砜膜有效弱化了正渗透膜的内浓差极化效应.     

Determination of Semicarbazide-Sensitive Amine Oxidase Activity in Blood Plasma by a Light Scattering Technique

A novel method for the determination of semicarbazide-sensitive amine oxidase (SSAO) activity in blood plasma has been developed. The method was based on the change of light scattering (LS) intensity resulting from the derivative product of the interaction of 2,4-dinitrophenylhydrazine (DNPH) with benzaldehyde produced by catalyzing of SSAO to benzylamine. In Britton-Robinson (B-R) buffer solution, the intensity of system's LS at 514.6 nm was significantly enhanced and was directly proportional to the concentration of benzaldehyde. In this method, SSAO enzyme activity is defined as the concentration of benzaldehyde (nmol) formed per mL plasma per hour. The range of determination of SSAO enzyme activity was 6.40 × 10^?3 ?0.340 nmol mL^?1 h^?1 with a detection limit of 1.92 × 10^?3 nmol mL^?1 h^?1. The relative standard deviation was 2.8–4.1% and the average recovery was 67.9% (n = 6).     

Flow Injection Chemiluminescence Determination of Phenol in Neutral Medium

A new flow injection chemiluminescence method for the determination of phenol was proposed, based upon the chemiluminescence reaction of phenol, N-bromosuccinimide, and hydrogen peroxide in neutral aqueous medium in the presence of cetyltrimethylammonium bromide surfactant micelles. The chemiluminescence signal was proportional to the concentration of phenol in the range of 1.0 × 10^?7?8.0 × 10^?6 g/mL with a detection limit of 3 × 10^?8 g/mL. The relative standard deviation for 1.0 × 10^?6 g/mL phenol solution was 2.0% (n = 11). The proposed method was successfully applied to the determination of phenol in phenol ear drops. A possible CL reaction mechanism was also discussed briefly.     

时间分辨后化学发光同时测定林可霉素和卡那霉素

根据林可霉素、卡那霉素在过氧化单硫酸盐(PMS)-鲁米诺(Luminol)体系中的化学发光反应动力学性质的明显差异,建立了时间分辨后化学发光同时测定林可霉素和卡那霉素的新方法.在PMS-鲁米诺体系中林可霉素化学发光反应较快,0.8s达到最大值,峰尖锐;卡那霉素化学发光反应较慢,54.8s后达到最大值,峰平缓,且其动力学曲线呈现出随时间分开的两个独立的发光峰,互不干扰.该方法测定林可霉素、卡那霉素的线性范围分别为4.0×10-9～8.0×10-7 g/mL、4.0×10-7～8.0×10-5 g/mL,对8.0×10-8 g/mL的林可霉素溶液和8.0×10-6 g/mL的卡那霉素溶液进行测定,其相对标准偏差(RSD,n=11)分别为4.6％和3.3％,测定林可霉素和卡那霉素的检出限分别为1.0×10-9 g/mL和1.0×10-7 g/mL.     

Method development and validation for simultaneous determination of ebastine and its active metabolite carebastine in human plasma by liquid chromatography–tandem mass spectrometry and its application to a clinical pharmacokinetic study in healthy Chinese volunteers

A simple LC–tandem mass spectrometry (MS/MS) method to determine ebastine and carebastine (active metabolite) in human plasma was developed and validated. Analytes and internal standards were precipitated by protein precipitation and separated on Synergi Hydro-RP 80A column (4 μm, 50 mm × 2.0 mm; Phenomenex) by gradient elution with mobile phase A comprising 0.1% formic acid in 5 mm ammonium acetate (NH₄Ac) and B comprising 100% methanol at a flow rate 0.4 mL/min. Ions were detected in positive multiple reaction monitoring mode, and they exhibited linearity over concentration range 0.01–8.0 and 1.00–300 ng/mL for ebastine and carebastine, respectively. A clinical pharmacokinetic study was conducted in healthy Chinese volunteers under fasting and fed conditions after a single oral administration of 10 mg ebastine. The maximum plasma concentration (C_max), time to C_max (T_max) and elimination half-life for ebastine were 0.679 ± 0.762 ng/mL, 1.67 ± 1.43 h and 7.86 ± 6.18 h, respectively, whereas these for carebastine were 143 ± 68.4 ng/mL, 5.00 ± 2.00 h and 17.4 ± 4.97 h, respectively under fasting conditions; the corresponding values under fed conditions were 4.13 ± 2.53 ng/mL, 3.18 ± 1.09 h and 21.6 ± 7.77 h for ebastine and 176 ± 68.4 ng/mL, 6.14 ± 2.0 h and 20.0 ± 4.97 h for carebastine.